Cyted Health Secures CAP Accreditation for U.S. Lab as DETECT-ME Validation Advances

New updates have been reported about Cyted Health.

Cyted Health has obtained College of American Pathologists accreditation for its U.S. laboratory, adding a key quality milestone to the CLIA certification it received in January 2024 and strengthening its readiness for broader commercial deployment of its gastrointestinal molecular diagnostics. The CAP designation confirms that Cyted Health’s operations, quality systems, and technical standards meet a widely recognized benchmark for pathology and lab medicine, an important credential for hospital partners, payers, and potential strategic collaborators.

In parallel, the company is running the DETECT-ME clinical validation study at multiple U.S. sites, designed to confirm the performance of new molecular assays that use the EndoSign collection device to detect esophageal conditions, including early-stage disease. The combination of active clinical validation and dual CLIA/CAP status positions Cyted Health to support future reimbursement discussions, scale its testing volume beyond the more than 40,000 assays already completed on its platform, and accelerate uptake of its minimally invasive approach to identifying Barrett’s esophagus and esophageal adenocarcinoma earlier in the care pathway.